SAPS3, EMRb | ABO or RhD blood group | ||||
---|---|---|---|---|---|
A | B | AB | RhD positive | ||
Mortality | |||||
28–day mortality | 1.05–1.05* | 0.93–1.07 | 0.87–1.08 | 0.91–1.23 | 0.94–1.11 |
90–day mortality | 1.04–1.05* | 0.95–1.08 | 0.88–1.07 | 0.94–1.25 | 0.93–1.10 |
Long-term mortalityc | 1.02–1.02* | 0.99–1.06 | 0.93–1.04 | 0.94–1.10 | 0.96–1.05 |
Morbidity | |||||
DAFventd | 1.05–1.05* | 0.99–1.12 | 0.94–1.13 | 0.93–1.21 | 0.97–1.13 |
DAFcirce | 1.04–1.04* | 0.92–1.03 | 0.95–1.15 | 0.97–1.27 | 0.93–1.08 |
SOFA-maxf | 1.06–1.07* | 0.95–1.09 | 0.94–1.15 | 0.93–1.24 | 0.91–1.07 |
Length-of-stay | 1.01–1.01* | 0.96–1.06 | 0.98–1.15 | 0.97–1.23 | 0.96–1.09 |